Literature DB >> 21067479

Choroideremia in a woman with ectodermal dysplasia and complex translocations involving chromosomes X, 1, and 3.

Krishna Mukkamala1, Ronald C Gentile, Judith Willner, Stephen Tsang.   

Abstract

BACKGROUND: Choroideremia is an X-linked recessive disorder characterized by vision loss with progressive atrophy of the retinal photoreceptors, retinal pigment epithelium (RPE), and choriocapillaris. Ectodermal dysplasia is a heterogeneous group of disorders characterized by a deficiency of two or more ectodermal derivatives. We report on the phenotypic and genetic characteristics of a 29-year-old woman with both choroideremia and ectodermal dysplasia.
MATERIALS AND METHODS: Observational case report with physical and ophthalmic examination, fluorescein angiography (FA), visual field testing, electroretinography, and cytogenetic analysis. This study adhered to the tenets of the Declaration of Helsinki and The New York Eye and Ear Infirmary Institutional Review Board guidelines.
RESULTS: Physical and ocular examination revealed hypotrichosis, hypohidrosis, full dentures, meibomian gland hypoplasia, and a decrease in corneal tear film. Visual acuity was hand motions in the right eye and 20/50 in the left eye. Fundus examination and fluorescein angiography were consistent with advanced choroideremia and revealed diffuse bilateral RPE and chorioretinal atrophy with sparing of the fovea. Visual field testing had less than 10-degree central islands in both eyes. Scotopic electroretinogram (ERG) was flat with a small flicker response. Cytogenetic analysis showed a complex translocation involving chromosomes X, 1, and 3: 46,X,t(X;1;3)(q13;q24;q21),inv(9)(p11q13). Selective inactivation of the normal X chromosome was present in blood and skin. Chromosomal analyses of the proband's family (mother and two brothers) were normal.
CONCLUSION: An X-autosome chromosomal translocation combined with non-random inactivation of the normal X-chromosome in a woman resulted in the phenotypic findings of choroideremia and ectodermal dysplasia.

Entities:  

Mesh:

Year:  2010        PMID: 21067479      PMCID: PMC3056021          DOI: 10.3109/13816810.2010.497529

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  13 in total

1.  Regional choroidal atrophy and alopecia. A new syndrome.

Authors:  J B Moloney; J Blake; B Denham; D Mooney
Journal:  Acta Ophthalmol (Copenh)       Date:  1988-06

2.  Prenatal diagnosis of choroideremia.

Authors:  M Schwartz; T Rosenberg
Journal:  Acta Ophthalmol Scand Suppl       Date:  1996

Review 3.  Molecular basis of choroideremia (CHM): mutations involving the Rab escort protein-1 (REP-1) gene.

Authors:  J A van den Hurk; M Schwartz; H van Bokhoven; T J van de Pol; L Bogerd; A J Pinckers; E M Bleeker-Wagemakers; I H Pawlowitzki; K Rüther; H H Ropers; F P Cremers
Journal:  Hum Mutat       Date:  1997       Impact factor: 4.878

4.  Mutational analysis of patients with the diagnosis of choroideremia.

Authors:  Kerry E McTaggart; Mai Tran; Dean Y Mah; Sarah W Lai; Nancy J Nesslinger; Ian M MacDonald
Journal:  Hum Mutat       Date:  2002-09       Impact factor: 4.878

5.  Fluorescein angiography of the hereditary choroidal dystrophies.

Authors:  K G Noble; R E Carr; I M Siegel
Journal:  Br J Ophthalmol       Date:  1977-01       Impact factor: 4.638

Review 6.  Choroideremia: new findings from ocular pathology and review of recent literature.

Authors:  Ian M MacDonald; Laurie Russell; Chi-Chao Chan
Journal:  Surv Ophthalmol       Date:  2009 May-Jun       Impact factor: 6.048

Review 7.  Choroideremia gene testing.

Authors:  Ian M MacDonald; Christina Sereda; Kerry McTaggart; Dean Mah
Journal:  Expert Rev Mol Diagn       Date:  2004-07       Impact factor: 5.225

8.  Association of ectodermal dysplasia, ectrodactyly and macular dystrophy: EEM syndrome (case report).

Authors:  M Hayakawa; K Yanashima; K Kato; A Nakajima; H Yamauchi
Journal:  Ophthalmic Paediatr Genet       Date:  1989-12

9.  A practical diagnostic test for choroideremia.

Authors:  I M MacDonald; D Y Mah; Y K Ho; R A Lewis; M C Seabra
Journal:  Ophthalmology       Date:  1998-09       Impact factor: 12.079

10.  Molecular basis for Rab prenylation.

Authors:  C Alory; W E Balch
Journal:  J Cell Biol       Date:  2000-07-10       Impact factor: 10.539

View more
  5 in total

1.  Clinical utility gene card for: choroideremia.

Authors:  Mariya Moosajee; Simon C Ramsden; Graeme C M Black; Miguel C Seabra; Andrew R Webster
Journal:  Eur J Hum Genet       Date:  2013-08-21       Impact factor: 4.246

2.  Clinical features, surgical outcomes and genetic analysis of ectodermal dysplasia with ocular diseases.

Authors:  Xi Chen; Wei-Xuan Zeng; Bao-Ying Duan; Yan-Yan Lin; Jia Liu; Zong-Duan Zhang
Journal:  Int J Ophthalmol       Date:  2022-07-18       Impact factor: 1.645

3.  Progress in the development of novel therapies for choroideremia.

Authors:  Jasmina Cehajic Kapetanovic; Maria I Patrício; Robert E MacLaren
Journal:  Expert Rev Ophthalmol       Date:  2019-12-26

4.  Ectodermal dysplasia associated with sickle cell disease.

Authors:  Luiz Evaristo Ricci Volpato; Maria Carmen Palma Faria Volpato; Artur Aburad de Carvalhosa; Vinicius Canavarros Palma; Alvaro Henrique Borges
Journal:  Case Rep Dent       Date:  2014-09-29

5.  Pathogenic mechanisms and the prospect of gene therapy for choroideremia.

Authors:  Ioannis S Dimopoulos; Stephanie Chan; Robert E MacLaren; Ian M MacDonald
Journal:  Expert Opin Orphan Drugs       Date:  2015-07-01       Impact factor: 0.694

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.